Showing 2591-2600 of 5771 results for "".
- Vision Expo Announces Virtual EYE2EYE Series, Launching April 15https://modernod.com/news/vision-expo-announces-virtual-eye2eye-series-launching-april-15/2477579/Vision Expo is launching the Virtual EYE2EYE Series, a series of virtual panels and interactive conversations inspired by Vision Expo’s EYE2EYE educational series. Launching Wednesday, April 15, the Virtual EYE2EYE Series will take place on a weekly basis with a new topic every Wednesday and Frid
- Aldeyra Therapeutics Announces Potential of ADX-629 to Treat COVID-19 Patientshttps://modernod.com/news/aldeyra-therapeutics-announces-potential-of-adx-629-to-treat-covid-19-patients/2477578/Aldeyra Therapeutics, which has several drug candidates for the treatment of ocular inflammatory diseases, plans to facilitate the clinical testing of its drug candidate ADX-629 in patients with COVID-19-associated respiratory compromise. The company has requested a pre-investigational new drug m
- Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Devicehttps://modernod.com/news/nano-retina-announces-preliminary-results-for-first-in-human-implantation-of-its-nr600-artificial-retina-device/2477482/Nano Retina, developer of the NR600, an artificial retina device that mimics the natural physiological processes of the human eye and restores functional vision to persons blinded by retinal degenerative diseases, reported preliminary results for first-in-human implantations of its artificial ret
- European Glaucoma Society Postpones Annual Congresshttps://modernod.com/news/european-glaucoma-society-postpones-annual-congress/2477472/The Executive Committee of the European Glaucoma Society has decided to postpone the 14th EGS Congress in Brussels, Belgium to December due to the global COVID-10 pandemic. A statement posted on the EGS website read: “In these times of uncertainty, the first
- MicroSurgical Technology (MST) Announces the Acquisition of IP and Assets of IRISS Medical Technologies Limitedhttps://modernod.com/news/microsurgical-technology-mst-announces-the-acquisition-of-ip-and-assets-of-iriss-medical-technologies-limited/2477460/MicroSurgical Technology (MST) has acquired the IP and assets of IRISS Medical Technologies Limited, a United Kingdom private limited company, related to the Volk Eye Check product and additional technology and intellectual property. Terms of the deal were not disclosed. The Volk E
- CooperVision Announces 2020 Best Practices Honoreeshttps://modernod.com/news/coopervision-announces-2020-best-practices-honorees/2477447/CooperVision has unveiled its 2020
- Oculis Announces Positive OCS-01 Phase 2 Data in Patients with Diabetic Macular Edema (DME)https://modernod.com/news/oculis-announces-positive-ocs-01-phase-2-data-in-patients-with-diabetic-macular-edema-dme/2477287/Oculis reported positive data from a phase 2 study of OCS-01, a novel eye drop formulation of dexamethasone, in development for the treatment of diabetic macular edema (DME), according to a company news release. OCS-01 was developed using Oculis’ proprietary Soluble NanoParticle technolog
- Aerie Pharmaceuticals Announces Positive Topline Results for Netarsudil in Phase 2 Study Conducted in Japanhttps://modernod.com/news/aerie-pharmaceuticals-announces-positive-topline-results-for-netarsudil-in-phase-2-study-conducted-in-japan/2477069/Aerie Pharmaceuticals reported positive topline results for the company’s phase 2 clinical trial evaluating netarsudil ophthalmic solution in Japanese patients. Netarsudil is a Rho kinase (ROCK) inhibitor specifically designed to increase outflow of aqueous humor through the trabecular meshwork,
- Vision 2020 USA to Hold Annual World Sight Day Briefing on October 17, 2019https://modernod.com/news/vision-2020-usa-to-hold-annual-world-sight-day-briefing-on-october-17-2019/2476939/As part of World Sight Day events, on Oct. 17, 2019, Vision 2020 USA will be holding an educational luncheon briefing at the Rayburn House Office Building, 2075, in aWashington DC, from noon to 1 p.m. According to Prevent Blindness, by 2050, the impaired and blind populations are projecte
- Eyewear and Eyecare Products Are Not Included in Recently Announced European Import Dutieshttps://modernod.com/news/eyewear-and-eyecare-products-are-not-included-in-recently-announced-european-import-duties/2476937/Eyewear and eyecare products are not among the European goods that will be subjected to new tariffs, according to a communication on behalf of The Vision Council to its members Thursday, as